Investors are closely watching Canadian cannabis stocks this week amid rising U.S. industry momentum. The U.S. cannabis market hit an estimated $38.5 billion in 2024 and may grow at a compound annual growth rate (CAGR) of about 11–12 percent through the late 2020s. Meanwhile, several states are advancing reform. Notably, Delaware began adult-use cannabis sales on August 1, 2025. Moreover, at the federal level, the Trump administration signaled plans to reschedule marijuana from Schedule I to Schedule III, possibly within weeks. This could ease restrictions and boost stock sentiment. Altogether, these developments underline strong thematic tailwinds. Thus, Canadian cannabis stocks with U.S. exposure stand to benefit from both legislative momentum and expanding consumer demand.
Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
President Trump announced Monday that his administration will consider cannabis rescheduling over the next few weeks. Canopy Growth rallied 24% on the news; Canadian LPs were up across the board. Canopy Growth reported improved Q1-2026 earnings last Friday with revenue growth and improved net loss.
7 Nov 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
6 Nov 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
8 Aug 2025 Date | | - Cons. EPS | - EPS |
7 Aug 2025 Date | | - Cons. EPS | - EPS |
30 May 2025 Date | | - Cons. EPS | - EPS |
7 Nov 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
6 Nov 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
8 Aug 2025 Date | | - Cons. EPS | - EPS |
7 Aug 2025 Date | | - Cons. EPS | - EPS |
30 May 2025 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Luc Mongeau CEO | TSX Exchange | CA1380351009 ISIN |
CA Country | 1,029 Employees | - Last Dividend | 20 Dec 2023 Last Split | - IPO Date |
Canopy Growth Corporation operates as a leading entity in the cannabis industry, focusing on the cultivation, distribution, and sale of cannabis and hemp-based products designed for both recreational and medicinal use. Its operations span across key markets including Canada, the United States, and Germany, positioning the company as a global player. The business is structured into two primary segments: Global Cannabis, which oversees the cannabis-related portfolio, and Other Consumer Products, which includes non-cannabis consumer products. Originally founded in 2009 and initially known as Tweed Marijuana Inc., the corporation rebranded to Canopy Growth Corporation in September 2015, signaling an expansion in its mission and product offerings. The company's headquarters are located in Smiths Falls, Canada, underscoring its Canadian roots and importance in the nation's growing cannabis industry.
In addition to these core offerings, Canopy Growth markets its products under a wide array of brands, each targeting different segments of the market. Notable brands include Tweed, for mainstream cannabis users; 7ACRES and DOJA, aimed at connoisseurs; Ace Valley and Quatreau for wellness-oriented consumers; and the Martha Stewart CBD brand, which underscores the company's entry into the health and lifestyle sector. The company also leverages partnerships and collaborations, as seen with brands like DNA Genetics and BioSteel, further diversifying its product landscape. High-quality vaping equipment from Storz & Bickel and wellness products from This Works round out Canopy Growth's extensive and varied product suite.